Top Biotechnology & Medical Research stocks in Europe
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
LONNLonza AG | CH₣37.95bn | 36.54 | 0.76% |
ARGXargenx SE | €20.68bn | n/a | n/a |
GMABGenmab A/S | DKK130.48bn | 24.19 | n/a |
BANBBACHEM HOLDING AG | CH₣6.25bn | 55.46 | 0.96% |
ZEALZealand Pharma A/S | DKK40.95bn | n/a | n/a |
MORMorphosys AG | €2.52bn | n/a | n/a |
BIONBB Biotech AG | CH₣2.25bn | 7.29 | 4.88% |
GLPGGalapagos NV | €1.76bn | 209.69 | n/a |
EVTEvotec SE | €1.69bn | n/a | n/a |
BIOA BBioArctic AB | SEK17.93bn | 78.36 | n/a |
GNSGenus | £1.25bn | 32.08 | 1.69% |
ALIF BAddLife AB | SEK13.19bn | 358.35 | 0.46% |
ABVXAbivax SA | €841.84m | n/a | n/a |
ERGOErgomed | £701.05m | 43.1 | n/a |
FYBFormycon AG | €754.83m | 6.47 | n/a |
GUBRAGubra A/S | DKK5.51bn | n/a | n/a |
PHILPhilogen SpA | €725.21m | n/a | n/a |
PRTCPuretech Health | £600.32m | n/a | n/a |
BSLNBasilea Pharmaceutica AG Allschwil | CH₣518.47m | 49.28 | n/a |
VLAValneva SE | €468.11m | n/a | n/a |